SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation
=============================================================================================================================================================

* Esther Redin
* Irati Garmendia
* Teresa Lozano
* Diego Serrano
* Yaiza Senent
* Miriam Redrado
* Maria Villalba
* Carlos E De Andrea
* Francisco Exposito
* Daniel Ajona
* Sergio Ortiz-Espinosa
* Ana Remirez
* Cristina Bertolo
* Cristina Sainz
* Juana Garcia-Pedrero
* Ruben Pio
* Juan Lasarte
* Jackeline Agorreta
* Luis M Montuenga
* Alfonso Calvo